<DOC>
	<DOCNO>NCT01629719</DOCNO>
	<brief_summary>Phase III clinical study , two sample , assessor blind purpose evaluate efficacy safety superiority use barium sulphate 66.7 % w/v ( Opti-bar ) contrast X-ray ( X-ray ) .</brief_summary>
	<brief_title>Study Phase III Comparison Superiority , Open With Blind Appraiser , Evaluate Efficacy Safety Barium Sulphate 66.7 % With V ( OPTI-BAR ) Compared Proceedings Inert Radiological Examinations Diagnosis Diseases Image Tratogastrointstinal</brief_title>
	<detailed_description />
	<criteria>Men woman 18 need xrays gastrointestinal tract contrast ; Healthy patient , ambulatory ; Willingness comply requirement study sign inform consent ( hit ) . Pregnant lactating woman ; Patients allergic barium sulfate , latex rubber simethicone ; Patients asthma , eczema , cystic fibrosis , heart disease , high blood pressure , rectal cancer , colostomy , obstruction stomach intestine , pseudotumor cerebri , block stomach intestinal disease , Hirsch pseudotumor cerebri ; Patients recently undergone rectal biopsy surgery recent history drilling esophagus , stomach intestine ; Patients already participate another clinical protocol last six month ; Other clinical criterion opinion study investigator could compromise welfare patient interfere result expect study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>